RFP | April 10, 2024
North Dakota Seeks Drug Maximum Allowable Cost Services
Restricted Content
You must be an Elite member to view this resource.
- About
- Markets
- Mental Health
- Addiction Treatment
- Child & Family Services
- I/DD & LTSS
- Social Services
- Chronic Disease Management
- Services
- Market Intelligence
- Executive Education
- Consulting & Technical Assistance
- Elite Membership
- Leadership & Management Certificate
- Customers
- Payer Organizations
- Technology Firms
- Provider Organizations
- Venture Capital Firms
- Pharmaceutical Companies
- Corporate
- Library
- Markets
- Mental Health
- Addiction Treatment Services
- Children & Family Services
- Autism & I/DD
- Disability Supports & Long Term Care
- Social Services
- Corrections
- Juvenile Justice
- Chronic Disease Management
- Health Care Systems
- Topics
- Technology & Information Management
- Treatment Innovation & Treatment Technology
- Managed Care & Value-Based Reimbursement
- Integrated Care Models
- Performance & Financial Management
- Strategy & Strategic Planning
- Marketing & Business Development
- Medicaid
- Medicare
- Mergers & Acquisitions
- Resources
- The News
- Executive Briefings
- Market Updates
- RFPs
- Market Intel Reports
- State Market Intelligence
- Organizational Profiles
- Program Profiles
- Library
- On-Demand Presentation
- Management Newsletter
- Assessments
- Institutes
- Summits
- Seminars
- Executive Roundtables
- VIP Networking Group
- IntelligenceExplorer
- The CFO Consortium
- Leadership & Management Certificate
- Databases
- Markets